Results 21 to 30 of about 168,851 (224)

Acquired severe aplastic anaemia: how medical therapy evolved in the 20th and 21st centuries

open access: yesBritish Journal of Haematology, 2021
The progress in aplastic anaemia (AA) management is one of success. Once an obscure entity resulting in death in most affected can now be successfully treated with either haematopoietic stem cell transplantation (HSCT) or immunosuppressive therapy (IST).
P. Scheinberg
semanticscholar   +1 more source

A case of severe aplastic anaemia after SARS‐CoV‐2 vaccination

open access: yesBritish Journal of Haematology, 2021
There is increasing awareness about the possible relationship between severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccines and the development of haematological diseases, including autoimmune cytopenias (AICs) and complement-mediated ...
N. Cecchi   +3 more
semanticscholar   +1 more source

COVID-19 infection in patients with severe aplastic anaemia

open access: yesBritish Journal of Haematology, 2021
The coronavirus disease 2019 (COVID-19) pandemic has caused concern among physicians caring for immunosuppressed patients. Aplastic anaemia (AA) is a rare life-threatening bone marrow failure disorder that presents with severe pancytopenia and a ...
C. Paton   +6 more
semanticscholar   +1 more source

REVESZ SYNDROME AND DIFFERENTIAL DIAGNOSIS OF PANCYTOPENIA AND APLASTIC ANEMIA – CASE REPORT

open access: yesSlovenska pediatrija, 2023
We are presenting a case of a boy with Revesz syndrome, and through an example of his diagnostic pathway, we are presenting a differential diagnosis of pancytopenia and aplastic anaemia. Revesz syndrome is a rare and severe form of dyskeratosis congenita,
Matjaž Homšak   +4 more
doaj   +1 more source

Implication of therapeutic outcomes associated with molecular characterization of paediatric aplastic anaemia

open access: yesBiochemistry and Biophysics Reports, 2021
Objectives: Severe aplastic anemia is characterized by a hypocellular bone marrow and peripheral cytopenia. Mesenchymal stem cells (MSCs) play a crucial role in haematopoietic stem cells (HSCs) development and the development of microenvironment suitable
Sarmistha Adhikari   +3 more
doaj   +1 more source

Parvovirus Infection Causing Aplastic Anaemia in an Immunocompetent Patient Diagnosed by Bone Marrow Aspiration Cytology [PDF]

open access: yesNational Journal of Laboratory Medicine, 2021
Human Parvovirus infection is associated with transient aplastic crisis as a most common complication in chronic haemolytic anaemia patients. Very few case reports are available regarding aplastic crisis in immunocompetent patients. Here the authors are
Ranjana Giri, Urmila Senapati
doaj   +1 more source

Aplastic anaemia treated using eltrombopag in a dog

open access: yes, 2023
2023 Acuerdos transformativos CRUEA 2-year-old, neutered, female beagle was presented to a referral hospital for investigation of pancytopenia. The patient had a history of recurrent infections and, on previous blood tests, anaemia, leukopenia and ...
Atencia Fernández, Sabela María   +3 more
core   +1 more source

Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open‐label study

open access: yesBritish Journal of Haematology, 2020
A previous dose‐finding study has suggested that romiplostim is effective in patients with refractory aplastic anaemia (AA) and 10 µg/kg once weekly was recommended as a starting dose.
J. Jang   +21 more
semanticscholar   +1 more source

Distinctive and common features of moderate aplastic anaemia

open access: yesBritish Journal of Haematology, 2020
The therapy algorithm for severe aplastic anaemia (sAA) is established but moderate AA (mAA), which likely reflects a more diverse pathogenic mechanism, often represents a treatment/management conundrum.
B. Patel   +14 more
semanticscholar   +1 more source

APLASTIC ANAEMIA – THERAPEUTIC AND DEONTOLOGICAL ASPECTS [PDF]

open access: yesRomanian Journal of Pediatrics, 2016
Aplastic Anaemia is a severe potentially fatal haematological syndrome, characterised by peripheral pancytopenia and bone marrow hypoplasia, with an occurrence rate of 2-6 cases per million per year.
Andreea Ligia Dinca   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy